TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
GLUE

Monte Rosa Therapeutics Inc

Healthcare · Biotechnology · —

12.60$ -0.4% vs. previous close Closing price · As of: Sep 17, 2026

Investor relations

Report Dates

Investor relations overview for Monte Rosa Therapeutics Inc (GLUE): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 11/05/2026.

Next report 11/05/2026
Last report 08/06/2026
Earnings surprise by quarter (%)
Q3 23 · 5.4 % 23 Q4 23 · -75.8 % 23 Q1 24 · 8.6 % 24 Q2 24 · 20.4 % 24 Q3 24 · 38.3 % 24 Q4 24 · -298.9 % 24 Q1 25 · 278.1 % 25 Q2 25 · 51.6 % 25 Q3 25 · 5.7 % 25 Q4 25 · -67.6 % 25 Q1 26 · -18.4 % 26 Q2 26 · -72.0 % 26

EPS estimate beaten

Full history 11 of 24 quarters (46%)
Last 16 quarters 9 of 16 quarters (56%)

Earnings Call Transcripts

Search all transcripts →

No transcripts yet — they will show up here automatically after the next earnings call.

News on This Stock

  • 09/08/2026 Monte Rosa Therapeutics, Inc. (GLUE): Regulation FD Disclosure; Other Events; Financial Statements and Exhibits · sec.gov Open ↗
  • 08/06/2026 Monte Rosa Therapeutics, Inc. (GLUE): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?